Cardiology (all articles) | Page 78 of 173 | Links Medicus Content Curation & Alerts in Medicine

Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation

4 May, 2021 | 08:38h | UTC

2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation – EP Europace

Commentary: EHRA Updates Its Popular ‘Practical’ NOAC Guide – TCTMD

Study: A high dietary sodium intake in patients with postural tachycardia syndrome reduces upright heart rate, increases plasma volume, lowers standing plasma norepinephrine, and decreases variability in heart rate

4 May, 2021 | 08:32h | UTC

Effect of High Dietary Sodium Intake in Patients With Postural Tachycardia Syndrome – Journal of the American College of Cardiology (link to abstract – $ for full-text)

Commentary: High Salt Intake Benefits Patients with Postural Tachycardia Syndrome – Medical Dialogues AND Effect of High Dietary Sodium Intake in POTS Patients – American College of Cardiology

Commentary on Twitter

Great new research from Vanderbilt documenting that a high salt diet reduces standing tachycardia and norepinephrine levels in POTS, but that even with a high salt diet, POTS patients have lower blood volume than healthy individuals. https://t.co/Fy4UcPmOyB pic.twitter.com/2ozUxzK8f6

— Dysautonomia Intl. (@Dysautonomia) April 26, 2021

M-A: Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease – “a 5 mm Hg reduction of systolic BP reduced the risk of major CV events by about 10%, irrespective of previous diagnoses of CV disease, and even at normal or high–normal BP values”

3 May, 2021 | 05:29h | UTC

Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis – The Lancet

Commentaries: Many more people could benefit from blood pressure-lowering medication – The Lancet AND Decisions about antihypertensive treatment should focus on reducing cardiovascular risk – The Lancet

Study: Patients with heart failure have a much higher incidence of pneumonia than matched individuals in the population. The development of pneumonia in these patients is associated with a 3- to 4-fold higher risk of cardiovascular and all-cause death.

3 May, 2021 | 05:18h | UTC

Incidence and Outcomes of Pneumonia in Patients With Heart Failure – Journal of the American College of Cardiology

Commentaries: Pneumonia in HF Patients Is Common, Lethal, and Preventable – TCTMD AND Outcomes of Pneumonia in Patients With Heart Failure – American College of Cardiology

AHA Statement: Management of Stage 1 Hypertension in Adults With a Low 10-Year Risk for Cardiovascular Disease – “There is a lack of randomized clinical trials that have evaluated CVD outcomes among individuals with stage 1 hypertension and a low 10-year ASCVD risk”

30 Apr, 2021 | 08:37h | UTC

Management of Stage 1 Hypertension in Adults With a Low 10-Year Risk for Cardiovascular Disease: Filling a Guidance Gap: A Scientific Statement From the American Heart Association – Hypertension

News Release: If slightly high blood pressure doesn’t respond to lifestyle change, medication can help – American Heart Association

Top Things to Know: Management of Stage 1 Hypertension in Adults With a Low 10-Year Risk for Cardiovascular Disease – American Heart Association

Commentary: The Hypertension Pandemic: Need for a Strategic Evidence-based Response – American Heart Association

AHA Statement: Prevention of Viridans Group Streptococcal Infective Endocarditis – Antibiotic prophylaxis for invasive dental procedures is suggested only for high-risk patients with the following conditions: 1) cardiac prosthetic valve; 2) previous infective endocarditis; 3) congenital heart disease; or 4) previous heart transplant

30 Apr, 2021 | 08:35h | UTC

Prevention of Viridans Group Streptococcal Infective Endocarditis: A Scientific Statement From the American Heart Association

News release: Good dental health may help prevent heart infection from mouth bacteria – American Heart Association

Top Things to Know: Prevention of Viridans Group Streptococcal Infective Endocarditis – American Heart Association

Slide set: Prevention of Viridans Group Streptococcal Infective Endocarditis

Commentaries: Commentary for Prevention of Viridans Group Streptococcal Infective Endocarditis – American Heart Association

Commentary on Twitter (thread – click for more)

#ScholarlySunday

In 2007, antibiotic prophylaxis to prevent VGS IE was scaled back.

“There was no convincing evidence that VGS IE frequency, morbidity, or mortality has increased since 2007.”

Thanks Drs. @LBaddour1, Daniel DeSimone and Walter Wilsonhttps://t.co/r9It8c3IwA pic.twitter.com/EO3gcKZAzG

— Mayo Clinic Infectious Diseases (@MayoClinicINFD) April 18, 2021

AHA Scientific Statement: Close monitoring for heart risk needed if breast, prostate cancer treatment includes hormonal therapies

29 Apr, 2021 | 08:33h | UTC

Impact of Hormonal Therapies for Treatment of Hormone-Dependent Cancers (Breast and Prostate) on the Cardiovascular System: Effects and Modifications: A Scientific Statement From the American Heart Association – Circulation: Genomic and Precision Medicine

News release: Close monitoring for heart risk needed if breast, prostate cancer treatment includes hormones – American Heart Association

Top Things to Know: Impact of Hormonal Therapies for Treatment of Hormone-Dependent Cancers (Breast and Prostate) on the Cardiovascular System – American Heart Association

Commentaries: Hormonal Therapy for Breast and Prostate Cancer: Lessons and Opportunities – American Heart Association AND Hormonal Based Therapies in the Treatment of Breast and Prostate Cancer – balancing the risks! – American Heart Association AND Hormone Cancer Therapies Increase CV Risk: AHA Scientific Statement – TCTMD AND Closely Monitor Heart Health in Cancer Patients Who Get Hormonal Therapies: AHA – HealthDay

USPSTF Statement recommends screening for hypertension in adults 18 years or older with office blood pressure measurement – diagnostic confirmation with blood pressure measurements outside of the clinical setting is advised before starting treatment

28 Apr, 2021 | 08:16h | UTC

Evidence Report: Screening for Hypertension in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force – JAMA

Author Interview: USPSTF Recommendation: Screening for Hypertension in Adults

Editorials: The USPSTF Recommendation on Blood Pressure Screening: Making 2021 the Transformative Year in Controlling Hypertension AND USPSTF Recommendation Statement on Hypertension Screening in Adults—Where Do We Go From Here? – JAMA Network Open AND Will the 2021 USPSTF Hypertension Screening Recommendation Decrease or Worsen Racial/Ethnic Disparities in Blood Pressure Control? – JAMA Network Open AND USPSTF Recommendations for Screening for Hypertension in Adults: It Is Time to Unmask Hypertensive Risk – JAMA Cardiology

JAMA Patient Page: Screening for Hypertension in Adults

NICE publishes updated clinical guideline on the diagnosis and management of atrial fibrillation

27 Apr, 2021 | 09:33h | UTC

Guideline: Atrial fibrillation: diagnosis and management – National Institute for Health and Care Excellence

News release: NICE publishes updated clinical guideline on the diagnosis and management of atrial fibrillation – National Institute for Health and Care Excellence

RCT: Reduced dose direct oral anticoagulants may be a safer option to vitamin K antagonists in hemodialysis patients with atrial fibrillation

27 Apr, 2021 | 09:27h | UTC

Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in Hemodialysis Patients with Atrial Fibrillation: A Multicenter Randomized Controlled Trial – Journal of the American Society of Nephrology (link to abstract – $ for full-text)

Commentary on Twitter

This study finds that patients on hemodialysis with atrial fibrillation experienced decreased cardiovascular events and major bleeding complications with direct oral anticoagulants compared with vitamin K antagonists https://t.co/6FOKkEXtfN pic.twitter.com/PD6qHaeZjT

— JASN_News (@JASN_News) March 22, 2021

Long Covid: Largest post-acute COVID-19 study to date examined the health outcomes in more than 73,000 people who’d had COVID-19 and were not hospitalized

23 Apr, 2021 | 08:48h | UTC

High-dimensional characterization of post-acute sequalae of COVID-19 – Nature

Commentary: Among COVID-19 survivors, an increased risk of death, serious illness – Washington University School of Medicine

Commentary on Twitter (thread – click for more)

Happy to share the latest paper from our team in @nature

A comprehensive characterization of post acute sequelae of COVID-19#longcovid #PASC https://t.co/AGLnYCamWe @VAResearch @vahsrd @WUSTL @WUSTLpubhealth @WUSTLmed @WUSTLnews @VREFSTL @Biostayan @BCBowe

— Ziyad Al-Aly, MD (@zalaly) April 22, 2021

AHA Scientific Statement: Obesity and Cardiovascular Disease

23 Apr, 2021 | 08:22h | UTC

Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association – Circulation

News Release: More belly weight increases danger of heart disease even if BMI does not indicate obesity – American Heart Association

Commentary: It’s time to measure your waistline, according to new recommendations. Belly fat raises your risk for disease – CNN

Long-Term Cardiovascular Outcomes in Systemic Lupus Erythematosus

23 Apr, 2021 | 08:08h | UTC

Cardiovascular Outcomes in Systemic Lupus Erythematosus – American College of Cardiology

Original study: Long-Term Cardiovascular Outcomes in Systemic Lupus Erythematosus – Journal of the American College of Cardiology (link to abstract – $ for full-text)

Review: Oral Antiplatelet Therapy After Acute Coronary Syndrome

22 Apr, 2021 | 08:22h | UTC

Oral Antiplatelet Therapy After Acute Coronary Syndrome: A Review – JAMA (free for a limited period)

Audio Clinical Review: Dual Antiplatelet Therapy After Acute Coronary Syndrome – JAMA

M-A: Aspirin alone better than dual antiplatelet therapy after transcatheter aortic valve implantation

22 Apr, 2021 | 08:20h | UTC

Aspirin Alone Versus Dual Antiplatelet Therapy After Transcatheter Aortic Valve Implantation: A Systematic Review and Patient‐Level Meta‐Analysis – Journal of the American Heart Association

Cohort study: Increased bleeding risk with no therapeutic benefit with the addition of aspirin to direct oral anticoagulant therapy when there is not a clear indication

21 Apr, 2021 | 06:34h | UTC

Adverse Events Associated With the Addition of Aspirin to Direct Oral Anticoagulant Therapy Without a Clear Indication – JAMA Internal Medicine (free for a limited period)

Commentaries: DOAC + Aspirin Common Without Clear Indication, Tied to More Bleeding – NEJM Journal Watch AND Many AFib patients wrongly prescribed aspirin therapy, study finds – UPI

Commentary on Twitter

Obs study in @JAMAInternalMed finds aspirin is often prescribed along w/ direct acting oral anticoagulant without clear reason and the combo *associates* w higher rates of bleeding https://t.co/nKsWtLnjr9

Good one @GBarnesMD

ASA is the number 1 drug I #deprescribe

— John Mandrola, MD (@drjohnm) April 19, 2021

Systematic review: Thrombolytic therapy for acute massive or submassive pulmonary embolism

21 Apr, 2021 | 06:20h | UTC

Thrombolytic therapy for pulmonary embolism – Cochrane Library

Summary: Drugs to dissolve pulmonary embolism (blood clot in the lungs) – Cochrane Library

USPSTF Draft Statement: Insufficient evidence to recommend screening for atrial fibrillation

21 Apr, 2021 | 06:42h | UTC

Draft Recommendation Statement: Screening for Atrial Fibrillation – U.S. Preventive Services Task Force

Commentary: Little evidence supports AFib screening in stroke prevention, group says – UPI

Guideline Synopsis: Management of Acute Coronary Syndromes in Patients Without Persistent ST-Segment Elevation

21 Apr, 2021 | 06:41h | UTC

Management of Acute Coronary Syndromes in Patients Without Persistent ST-Segment Elevation – JAMA (free for a limited period)

Original guideline: #ESCCongress – 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation AND Summary: The ‘Ten Commandments’ for the 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation – European Heart Journal

M-A: Guided versus standard antiplatelet therapy in patients undergoing percutaneous coronary intervention

20 Apr, 2021 | 05:40h | UTC

Guided versus standard antiplatelet therapy in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis – The Lancet

Commentary on Twitter

Great paper on guided vs standard DAPT.
Interestingly outcomes were found to vary according to the strategy used:
ESCALATION was associated with⬇️ISCHEMIC EVENTS (without⬆️bleedings)
DE-ESCALATION was associated with⬇️ BLEEDINGS (without ⬆️ischemic events). https://t.co/y4ys6tvktw

— Gregory A. Sgueglia (@GregorySgueglia) April 16, 2021

Large cohort finds low risk of SARS-CoV-2 cardiac involvement in young competitive athletes

20 Apr, 2021 | 06:04h | UTC

SARS-CoV-2 Cardiac Involvement in Young Competitive Athletes – Circulation

News Release: Study: Heart setbacks from COVID-19 unlikely in athletes – UW Medicine

2021 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult

18 Apr, 2021 | 21:24h | UTC

2021 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult – Canadian Journal of Cardiology

Commentary on Twitter

Check out the latest @SCC_CCS Guideline for the Management of Dyslipidemia for the Prevention of #Cardiovascular Disease!! https://t.co/ZKC7DrMIOq #HotOffThePress @ThanassoulisMD @ArdenBarry @DrNatDayan @RuthMcPherson12 @HeartDocRx @SCC_CCS_KT @SCC_CCS_CEO @SCC_CCS_Trainee pic.twitter.com/LZFbXNjztP

— CJC (@CJC_JCC) March 27, 2021